SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-267350
Filing Date
2021-09-08
Accepted
2021-09-08 08:31:19
Documents
58
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d340732d10q.htm   iXBRL 10-Q 1711605
2 EX-31.1 d340732dex311.htm EX-31.1 11223
3 EX-31.2 d340732dex312.htm EX-31.2 11179
4 EX-32.1 d340732dex321.htm EX-32.1 6457
  Complete submission text file 0001193125-21-267350.txt   4804150

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nuvl-20210630.xsd EX-101.SCH 32616
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nuvl-20210630_cal.xml EX-101.CAL 20982
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvl-20210630_def.xml EX-101.DEF 182517
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvl-20210630_lab.xml EX-101.LAB 255361
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvl-20210630_pre.xml EX-101.PRE 229817
10 EXTRACTED XBRL INSTANCE DOCUMENT d340732d10q_htm.xml XML 464374
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40671 | Film No.: 211240799
SIC: 2834 Pharmaceutical Preparations